USD 559.65 Million
Pneumonia Testing Market Size, Share, and Growth Analysis
Pneumonia Testing Market By Product Type (Reagents & Consumables, Instruments), By type (Streptococcus-Based, Viral Pneumonia-Based), By End User (Hospitals & Clinics, Diagnostic Centers), By Region -Industry Forecast 2024-2032
Report ID:
SQMIG35D2250 |
Region:
Global |
Published Date: October, 2024
Pages:
219
|Tables:
117
|Figures:
72
Format -
Pneumonia Testing Market Insights
Pneumonia Testing Market size was valued at USD 559.65 Million in 2023 and is poised to grow from USD 596.59 Million in 2024 to USD 994.79 Million by 2032, growing at a CAGR of 6.60% during the forecast period (2025-2032).
The growing incidence and early diagnosis of pneumonia, with the associated rising concern of the disease, have fueled the pneumonia testing market growth. With the COVID-19 pandemic, there has been a huge increase in viral pneumonia cases, owing to the fact that the patients infected with COVID-19 are more predicted to suffer from pneumonia. Strict lockdown measures also resulted in fewer visits to medical professionals; hence, the cases of pneumonia acquired in the community also dropped. The market will rise due to significant technological breakthroughs, among them nucleic acid detection, and increased government and non-government organizations' attempts towards raising awareness and encouraging appropriate diagnosis towards pneumonia. Besides, pneumonia-related deaths among children in underdeveloped countries are driven by a series of poverty-related factors, such as malnutrition, unavailability of sanitary facilities and clean water supply, indoor and outdoor pollution, and insufficient healthcare services. Hence, governments of developing countries are worried about the launching of programs that increase the awareness level regarding the diagnosis of pneumonia to reduce death rates caused by an increasing mortality rate due to pneumonia. The American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) released Community-Acquired Pneumonia (CAP) guidelines since the detection of pneumonia is a bigger concern in developed countries. Developed countries are expected to follow such pneumonia testing guidelines for the detection of pneumonia to increase awareness of such testing procedures. Consequently, the above factors are the most influential drivers of the growth of the global market during the forecast period.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Reagents & Consumables
Fastest Growth
Instruments
Growth Rate
6.60% CAGR
Global Pneumonia Testing Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Pneumonia Testing Market Segments Analysis
Global Pneumonia Testing Market is segmented by Product Type, Type, End-user, and region. Based on Product Type, the market is segmented into Instruments, Reagents & Consumables. Based on Type, the market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others. Based on End-user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Pneumonia Testing Market Analysis by Product Type
Based on the 2023 pneumonia testing market analysis, the reagents & consumables segment accounted for a huge percentage of the market share. This is due to increased R&D projects within the healthcare and life sciences sectors, the introduction of novel products is enhancing demand for reagents and consumables. Such goods include those on which the various clinical assays, microbiological testing, and other diagnostic tests rely in laboratories. The use of rapid microbiological testing has increased because of its ever-growing importance in clinical and environmental settings. Moreover, the leadership maintained by the segment in the market is further reinforced by the stable demand for consumables in academia, pharmaceutical, and biotechnology research, thus reinforcing its stand in promoting scientific and medical advancement.
However, the instruments category is expected to rise substantially from 2024 to 2031, driven by the continuous advancement of cutting-edge technology in laboratory equipment and diagnostics. Apart from making testing more efficient and precise, new instrument improvements are also increasing access to diagnostics in many geographical areas. It is expected that the increasing adoption of this state-of-the-art equipment in clinics, hospitals, and research centers worldwide will propel the market. In addition, laboratory instruments are becoming more powerful, processes are becoming more efficient, and human error is being reduced because of the integration of automation and artificial intelligence (AI). The instruments segment is expected to increase significantly as technology continues to progress, revolutionizing healthcare procedures globally.
Pneumonia Testing Market Analysis By Type
As per the 2023 pneumonia testing market forecast, the streptococcus-based category led the market since streptococcus pneumoniae is one of the main agents causing community-acquired pneumonia (CAP). It accounts for a significant share of pneumonia cases in the global landscape. According to a report from the National Institutes of Health, published in 2022, this bacterium is accountable for about 15.0% of pneumonia cases in the US and 27.0% globally. The wide spread of the pathogen makes it an extremely high-demand pneumonia diagnosis test that is fast and accurate. Due to this reason, this market category still rules the pneumonia testing market as a result of constant research and improved diagnostic capabilities, ensuring better patient outcomes through early diagnosis.
Contrarily, growing viral pneumonia cases, especially caused by respiratory viruses such as influenza and COVID-19, is expected to further propel the viral pneumonia-based segment to the second leading position in the pneumonia testing market during the forecast period. Due to increased awareness of viral pneumonia triggered by the COVID-19 pandemic, hospitalizations have gone up, and there is an added requirement for accurate microbiological testing. This segment is driven by the increased incidence of viral respiratory infections as well as advances in diagnostic technology. It will continue to expand as the medical professionals focus on the differentiation between bacterial and viral infections to make better treatment choices and reduce costs.
Global Pneumonia Testing Market By Product Type
To get detailed analysis on other segments, Request For Free Sample Report
Pneumonia Testing Market Regional Insights
North America held a significant share of the pneumonia testing industry during the forecast period, with a market value of USD 254.3 million in 2023. This is due to two reasons: the high rate of pneumonia cases in the region and the rapid adoption of point-of-care technology, which enables faster and more effective diagnostics. Besides this, the United States' attractive payment rules also promote healthcare providers to invest in modern diagnostic instruments. The North America pneumonia testing market has major market participants, and it is also experiencing the entry of technologically advanced products.
Due to a number of factors, the European market had the second biggest market share in 2023. Since respiratory conditions comprise a significant percentage of in-hospital mortality, one major factor is the increase in hospitalizations caused by pneumonia. According to a January 2021 BMC research, respiratory disorders account for 15.0% of in-hospital mortality in European nations, with pneumonia ranking as the second most common cause. Besides this, pneumonia accounts for 2.0% of the overall hospital shares and 7.0% of all hospital admissions. Demand for pneumonia testing in the area is expected to go on an increase due to public sensitization efforts that various governments within Europe have initiated for creating awareness among the members of public about pneumonia.
Global Pneumonia Testing Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Pneumonia Testing Market Dynamics
Pneumonia Testing Market Drivers
Increasing Pneumonia Cases
-
An important driving factor behind the pneumonia testing market is the growing prevalence of cases of pneumonia, due to growing geriatric population, respiratory infections, and environmental factors. Pneumonia is still one of the leading causes of hospitalization and death. Besides, there is an increasing demand for accurate and quick diagnostic tests so early diagnosis and effective treatment can be undertaken.
Advancements in Diagnostic Technologies
-
The recent technological advancements in pneumonia testing, which include the production of molecular diagnostic tools and the rapid point-of-care tests, have played a significant role in propelling further the expansion of the pneumonia testing market. Thus, these technological advancements indicate that patients will be identified much more rapidly and accurately, improving patient outcome and efficacy of health care systems in low-resource settings.
Pneumonia Testing Market Restraints
High-End Advanced Diagnostic Equipment
-
The adoption may be limited by the high cost of advanced diagnostic technologies and techniques, such as PCR-based testing and molecular diagnostics, especially in underdeveloped regions or in health centers with low budgets. This limits the growth of the industry since it creates a barrier to universal access to quality pneumonia testing.
Lack of Information in Developing Regions
-
The problem is that most of the developing countries lack knowledge of the need to test for pneumonia, hence the early diagnosis is not known. Most markets have been limited to increase because of the increasing rate of morbidity and deaths related to a lack of infrastructures, resources, or knowledge to test for pneumonia.
Request Free Customization of this report to help us to meet your business objectives.
Pneumonia Testing Market Competitive Landscape
The global pneumonia testing market features a competitive landscape characterized by the presence of several key players striving to gain a competitive edge through various market-specific strategies. Leading companies in the market, such as Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc., are focusing on innovative product development, strategic partnerships, and geographical expansion to strengthen their market position.
In terms of product development, companies are investing in research and development activities to introduce advanced pneumonia testing solutions with improved accuracy, sensitivity, and efficiency. For instance, they are developing molecular diagnostic assays capable of detecting a wide range of pneumonia-causing pathogens rapidly. Additionally, there is a growing emphasis on developing point-of-care testing devices that offer rapid results and can be used in diverse healthcare settings, including hospitals, clinics, and remote areas.
Strategic partnerships and collaborations play a vital role in the competitive landscape of the pneumonia testing market. Companies are forming partnerships with healthcare providers, diagnostic laboratories, and research institutions to expand their customer base, enhance product offerings, and access new market segments. Furthermore, collaborations with regulatory agencies and professional organizations help companies navigate regulatory hurdles and stay abreast of evolving industry standards and guidelines.
Geographical expansion is another key strategy employed by market players to capitalize on emerging market opportunities and strengthen their global presence. Companies are expanding their distribution networks, establishing subsidiaries and manufacturing facilities in key growth markets, and entering strategic alliances with local distributors to penetrate untapped markets effectively. Additionally, they are investing in marketing and promotional activities to raise awareness about pneumonia testing solutions and drive adoption among healthcare providers and patients.
Top Players in Pneumonia Testing Market
- Thermo Fisher Scientific Inc. (US)
- Quidel Corporation (US)
- Becton, Dickinson, and Company (US)
- Meridian Bioscience, Inc. (US)
- Qiagen N.V. (Netherlands)
- bioMerieux SA (France)
- Bio-Rad Laboratories Inc. (US)
- Cardinal Health Inc. (US)
- Hologic Inc. (US)
- La Roche Ltd. (Switzerland)
- Abbott Laboratories (US)
- Quest Diagnostics (US)
- Luminex Corporation (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agena Bioscience, Inc. (US)
- Roche Diagnostics (Switzerland)
- Grifols, S.A. (Spain)
- PerkinElmer, Inc. (US)
- Genoa Healthcare, LLC (US)
- SeraCare Life Sciences, Inc. (US)
- Randox Laboratories Ltd. (UK)
- Acon Laboratories, Inc. (US)
Pneumonia Testing Market Recent Developments
- In December 2023, Thermo Fisher Scientific, Inc. launched the KingFisher Apex Dx, an automated nucleic acid purification device designed to purify and isolate bacterial and viral pathogens from respiratory biological materials, and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit.
- In September 2021, the CE-IVD multiplex test VIASURE C. pneumoniae, M. pneumoniae, & L. pneumophila real-time PCR kit was developed and validated by CerTest Biotec for the identification of the major pathogens associated with atypical pneumoniae.
- In April 2021, Lumos Diagnostics and Luminex Corporation (DiaSorin S.p.A.) partnered to launch LIAISON IQ, an immunoassay Point-of-Care (POC) platform that offers accessible POC solutions in under 15 minutes.
Pneumonia Testing Key Market Trends
- Combination of Automation and AI: Pneumonia testing technologies are fast adopting automation and artificial intelligence to process test data faster and with more accuracy. One of the most significant pneumonia testing market trends is the application of AI-based systems that help doctors interpret data more efficiently, reducing human errors and increasing the accuracy of diagnosis.
- Increasing Application of Point-of-Care Tests: Point-of-care testing of pneumonia is gaining acceptance in view of its ease, speed of performance, and acceptability in out-of-laboratory settings. In this regard, since the immediate diagnosis may significantly determine better outcomes for patients while also saving healthcare costs, the tendency is highly prominent in emergency services, rural areas, and in less affluent countries.
Pneumonia Testing Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the increasing cases of pneumonia globally, technological advancements in diagnostics, and the increasing demand for faster and more accurate testing methodologies are all expected to fuel the pneumonia testing market for massive growth. Important drivers for the future of this market include point-of-care testing and the integration of automation and artificial intelligence into diagnostic platforms. Growth may be restricted, however, by problems such as high testing prices and low awareness in developing countries. Despite these challenges, the market is expected to expand due to ongoing innovations from key players and the growing demand for pneumonia treatment and early detection. In the next few years, this vibrant industry will hold opportunities both for strategic alliances and technical innovation.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 559.65 Million |
| Market size value in 2032 | USD 994.79 Million |
| Growth Rate | 6.60% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Pneumonia Testing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Pneumonia Testing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Pneumonia Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pneumonia Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pneumonia Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pneumonia Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Pneumonia Testing Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
